How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey

Best Practice for Atrial Fibrillation Patient Education

(2014) Deirdre Lane et al.   CURRENT PHARMACEUTICAL DESIGN

Patient’s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation

(2014) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey

(2013) G. Y. H. Lip et al.   EUROPACE

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

(2013) Hein Heidbuchel et al.   EUROPACE

Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control

(2012) Allan C. Skanes et al.   CANADIAN JOURNAL OF CARDIOLOGY

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation

(2011) Tatjana S. Potpara et al.   CHEST

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality

(2010) E. Aliot et al.   EUROPACE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE